Can growth hormone or DHEA help women with low egg reserve get pregnant?

NCT ID NCT07323329

Recruiting now Disease control Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving growth hormone or DHEA (a natural hormone) can improve egg production and pregnancy rates in women with poor ovarian reserve who are undergoing IVF. 165 women will receive one of these treatments or a placebo (folic acid only) for 1-3 months before their IVF cycle. The goal is to see which approach leads to more mature eggs and higher pregnancy rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Somatropin (growth hormone) and dehydroepiandrosterone (DHEA)
What this could lead to: If it works, this could offer a way to improve egg quantity and quality in women with poor ovarian reserve, potentially increasing their chances of pregnancy through IVF.
What could go wrong: This is a mid-stage trial with only 165 participants, so results may not apply to everyone. Hormone treatments can have side effects, and success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY INFERTILITY (IVF PATIENTS)

Contacts and locations

Locations

Beni-Suef University Hospital
RECRUITING

Banī Suwayf, Beni Suweif Governorate, 62521, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.